TY  - JOUR

T1  - Late Treatment With Autologous Expanded Regulatory T-cell Therapy After Alemtuzumab Induction Is Safe and Facilitates Immunosuppression Minimization in Living Donor Renal Transplantation

JO  - Transplantation

UR  - https://doi.org/10.1097/tp.0000000000005065

PY  - 2024/10/22

AU  - Brook MO

AU  - Hennessy C

AU  - Hester J

AU  - Hammad S

AU  - Alzhrani A

AU  - Rombach I

AU  - Dutton S

AU  - Lombardi G

AU  - Wood KJ

AU  - Friend P

AU  - Harden PN et al

ED  - 

DO  - DOI: 10.1097/tp.0000000000005065

PB  - Ovid Technologies (Wolters Kluwer Health)

VL  - 108

IS  - 11

SP  - 2278

EP  - 2286

Y2  - 2025/05/21

ER  -